{"count":2,"index":{"built_at":"2026-07-27T00:38:48.414078+00:00","public_records":55311,"revision":"b87c7f9f152476c0a11ddb39"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: Pharmakogenetik Medicheck in the context of fatigue"},"results":[{"answer":"The question about a pharmacogenetic Medicheck for fatigue is understandable, but the evidence for routine use is weak. Fatigue is a multifactorial symptom caused by sleep deprivation, stress, diet, lack of exercise, or underlying conditions (e.g., anemia, thyroid disorders). Pharmacogenetic tests analyze gene variants affecting drug metabolism (e.g., CYP2D6, CYP2C19). In fatigue, they could theoretically help if medications like antidepressants or beta-blockers are the cause – yet clinical relevance is limited. Most studies show small effect sizes, and prospective data proving that test-guided dosing improves fatigue are lacking. The MyBody-X test is not specifically described for pharmacogenetics in fatigue in the provided context; available information refers to stress DNA tests without confirmed SNP panels. Therefore, the evidence grade is 'unclear'. A medical workup for fatigue (including blood count, ferritin, thyroid) is more appropriate before genetic testing.","area":"gesundheit","canonical_id":"gesundheit:canonical-6e356f2a571d2e85d03db890","id":"public-b2a1015ccbd5b37b2684b68b","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Pharmakogenetik Medicheck in the context of Müdigkeit","score":33.47959785,"snippet":"The question about a pharmacogenetic Medicheck for fatigue is understandable, but the evidence for routine use is weak. Fatigue is a multifactorial symptom caused by sleep deprivation, stress, diet, lack of exercise, or underlying conditions (e.g., anemia, thyroid disorders). Pharmacogenetic tests analyze gene variants affecting drug metabolism (e.g., CYP2D6, CYP2C19). In fatigue, they could theoretically help if medications like antidepressants or beta-blockers are the cause – yet clinical relevance is limited. Most studies show small effect sizes, and prospective data proving that test-guided dosing improves fatigue are lacking. The MyBody-X test is not specifically described for pharmacog","sources":[],"title":"Evidence check: Pharmakogenetik Medicheck in the context of Müdigkeit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-b2a1015ccbd5b37b2684b68b/evidence-check-pharmakogenetik-medicheck-in-the-context-of-muedigkeit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Pharmacogenetic (PGx) testing can reveal how an individual metabolizes drugs via enzymes like CYP450. In the context of fatigue, a PGx check might theoretically identify whether a medication (e.g., antidepressant, statin) is being processed too slowly or too quickly, leading to side effects or inefficacy. However, the evidence for routine PGx screening in fatigue without a specific drug regimen is weak. Most research focuses on drug response phenotypes, not fatigue as a primary endpoint. Effect sizes of common variants are moderate at best. Therefore, a PGx test may be useful only if the patient is already on medication and a pharmacogenetic issue is suspected. Without a thorough medical workup and medication history, the test lacks clinical utility. Fatigue is multifactorial (sleep, nutrition, stress, hormones, infections) and should be evaluated by a physician first. MyBody-X provides genetic data but not a diagnosis. The evidence level for this specific use case is 'unclear' because no robust studies directly link PGx testing to fatigue management.","area":"gesundheit","canonical_id":"gesundheit:canonical-2ee761b152f8230628526f62","id":"public-89404979cabc00a74be1b1e6","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Pharmakogenetik Medicheck in the context of fatigue","score":33.37621086,"snippet":"Pharmacogenetic (PGx) testing can reveal how an individual metabolizes drugs via enzymes like CYP450. In the context of fatigue, a PGx check might theoretically identify whether a medication (e.g., antidepressant, statin) is being processed too slowly or too quickly, leading to side effects or inefficacy. However, the evidence for routine PGx screening in fatigue without a specific drug regimen is weak. Most research focuses on drug response phenotypes, not fatigue as a primary endpoint. Effect sizes of common variants are moderate at best. Therefore, a PGx test may be useful only if the patient is already on medication and a pharmacogenetic issue is suspected. Without a thorough medical wor","sources":[],"title":"Evidence check: Pharmakogenetik Medicheck in the context of fatigue","url":"https://tikki.wiki/wissen/gesundheit/frage/public-89404979cabc00a74be1b1e6/evidence-check-pharmakogenetik-medicheck-in-the-context-of-fatigue/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}